Website & contact details
- Website
Orchid Cellmark Ltd
- Incorporated
- 28 July 2000 (26 years)
- Industry
- Technical testing and analysis (71200)
- Owned by
- Eurofins Scientific S.E.
- Accounts type
- Full
- Region
- West Midlands
- Address
- Unit G1 Valiant WayI54 Business ParkWolverhamptonWV9 5GB
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 11 August 2027
- Last conf. stmt
- 28 July 2026
Charges
- Total
- 5
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 5
Officers 4 active
Officer details are public data from the Companies House register.
Director · Appointed 1 July 2025
British
Born September 1980 (46)
Director · Appointed 20 August 2024
British
Born November 1967
Director · Appointed 20 August 2024
British
Born April 1980 (46)
Ganderton, Laura Jayne
Secretary · Appointed 20 August 2024
Officer history (24 former)
1 July 2025
18 March 2025
20 August 2024
20 August 2024
20 August 2024
Appointed Ganderton, Laura Jayne as Secretary
20 August 2024
20 August 2024
7 August 2018
7 August 2018
Resigned Sisec Limited as Corporate Secretary
7 August 2018
12 May 2017
30 April 2017
Resigned Derbyshire, Roger Bernard as Director
6 August 2012
Appointed Sisec Limited as Corporate Secretary
7 June 2012
16 December 2011
Resigned Bologna, Thomas as Director
16 December 2011
Resigned Bologna, Thomas as Secretary
9 December 2008
Appointed Derbyshire, Roger Bernard as Director
2 December 2008
26 October 2008
Resigned Fox, Mark Wilson, Finance Director as Director
4 March 2007
Resigned Meltzer, Warrent., Vice President And General Counsel as Secretary
4 March 2007
Appointed Bologna, Thomas as Director
4 March 2007
Resigned Meltzer, Warrent., Vice President And General Counsel as Director
4 March 2007
Appointed Bologna, Thomas as Secretary
1 September 2006
Resigned Kelly, Paul as Director
1 September 2006
Resigned Land, Raymond as Director
15 December 2005
Appointed Fox, Mark Wilson, Finance Director as Director
28 October 2005
6 June 2005
Appointed Land, Raymond as Director
8 March 2005
Appointed Meltzer, Warrent., Vice President And General Counsel as Director
8 March 2005
Appointed Meltzer, Warrent., Vice President And General Counsel as Secretary
31 December 2004
Resigned Spicer, Michael as Secretary
31 December 2004
Resigned Spicer, Michael as Director
9 July 2003
Appointed Spicer, Michael as Secretary
9 July 2003
Appointed Kelly, Paul as Director
9 July 2003
Appointed Spicer, Michael as Director
7 July 2003
Resigned Savadelis, Andrew as Secretary
7 July 2003
Resigned Savadelis, Andrew as Director
31 January 2003
9 December 2002
Resigned Pfost, Dale as Director
29 September 2002
Appointed Savadelis, Andrew as Director
29 September 2002
29 September 2002
29 September 2002
Appointed Savadelis, Andrew as Secretary
24 September 2002
5 September 2000
28 July 2000
28 July 2000
28 July 2000
28 July 2000
28 July 2000
28 July 2000
Appointed Pfost, Dale as Director
28 July 2000
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Eurofins Scientific S.E.
Corporate entity · Notified 16 April 2025
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. B167775
Holdings 1
Companies where Orchid Cellmark Ltd is registered as a person with significant control
Owns 75–100% of shares
Active
Former controllers (2)
16 April 2025
Ceased Dnaco — Owns 75–100% of shares
7 August 2018
Ceased Laboratory Corporation of America Holdings — Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- (£5,866,000)
- Cash
- £335,000
- Turnover
- £33,104,000
- Profit Before Tax
- (£6,627,000)
- Debt Ratio
- 157%
- Current Ratio
- 0.7x
- Profit Margin
- -20%
Trend
Turnover
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fixed Assets | £666,000 | £1,455,000 | £1,631,000 | £976,000 | £867,000 |
| Current Assets | £9,611,000 | £5,233,000 | £5,872,000 | £9,933,000 | £12,081,000 |
| Debtors | £8,663,000 | £3,292,000 | £3,830,000 | £5,851,000 | £6,597,000 |
| Cash | £335,000 | £157,000 | £157,000 | £1,144,000 | £2,184,000 |
| Creditors (< 1 year) | £13,728,000 | £7,007,000 | £4,201,000 | £4,981,000 | |
| Creditors (> 1 year) | £20,000 | £66,000 | £28,000 | ||
| Net Current Assets | (£4,117,000) | (£3,049,000) | (£1,135,000) | £5,732,000 | £7,100,000 |
| Net Assets | (£5,866,000) | (£2,855,000) | (£354,000) | £6,133,000 | £7,247,000 |
| Shareholder Funds | (£5,866,000) | (£2,855,000) | (£354,000) | £6,133,000 | £7,247,000 |
| Turnover | £33,104,000 | £31,827,000 | £28,192,000 | £30,115,000 | £28,900,000 |
| Cost of Sales | £8,448,000 | £26,823,000 | £27,063,000 | £24,897,000 | £23,211,000 |
| Gross Profit | £24,656,000 | £5,004,000 | £1,129,000 | £5,218,000 | £5,689,000 |
| Admin Expenses | £31,155,000 | £7,464,000 | £7,119,000 | £6,013,000 | £5,852,000 |
| Staff Costs | £22,639,000 | £21,310,000 | £20,942,000 | £18,992,000 | £17,872,000 |
| Profit Before Tax | (£6,627,000) | (£2,460,000) | (£5,990,000) | (£794,000) | £40,000 |
| Tax | £41,000 | £497,000 | £320,000 | (£97,000) | |
| Profit for Period | (£6,627,000) | (£2,501,000) | (£6,487,000) | (£1,114,000) | £137,000 |
Filings 146
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 27 August 2026 | Confirmation statement with updates | 28 July 2026 | ||
| 26 August 2026 | Replacement filing for the appointment of a director | |||
| 31 July 2026 | Full accounts | 31 December 2025 | ||
| 7 November 2025 | Statement of capital following an allotment of shares | |||
| 5 August 2025 | Confirmation statement with updates | 28 July 2025 |
Some other companies at this address
Other companies in this industry
Warrington
Liverpool
London
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →